katblat

$CRSP - IHS looks good

做多
NASDAQ:CRSP   CRISPR Therapeutics AG
CRSP has better IHS than edit but no unusual call option buying.
Watching until we are above and holding 50 SMA.

better not bitter
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。